Publications by authors named "Suoping Zhai"

Claim this Profile
D
Dose-Dependent Effect of Piragliatin, a Glucokinase Activator, on the QT Interval Following Short-Term Multiple Doses in Patients With Type 2 Diabetes Mellitus.
Jianguo Zhi, Suoping Zhai, Mark Boldrin

Clin Pharmacol Drug Dev· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of Potential Pharmacokinetic and Pharmacodynamic Interactions Between Piragliatin, a Glucokinase Activator, and Simvastatin in Patients With Type 2 Diabetes Mellitus.
Angela Georgy, Suoping Zhai, Zhenming Liang, Mark Boldrin, Jianguo Zhi

J Clin Pharmacol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory effects of a strong CYP3A inhibitor (ketoconazole), a strong CYP3A inducer (rifampicin), and concomitant ethanol on piragliatin pharmacokinetics and pharmacodynamics in type 2 diabetic patients.
Jianguo Zhi, Suoping Zhai, Angela Georgy, Zhenming Liang, Mark Boldrin

J Clin Pharmacol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of piragliatin, a glucokinase activator, on fasting and postprandial plasma glucose in patients with type 2 diabetes mellitus.
Jianguo Zhi, Suoping Zhai

J Clin Pharmacol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases.
William D Figg, Yinong Liu, Philip Arlen, James Gulley, Seth M Steinberg, Suoping Zhai

J Urol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancer.
Antoinette R Tan, Xiaowei Yang, Arlene Berman, Suoping Zhai, Alex Sparreboom

Clin Cancer Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of midazolam in human plasma by liquid chromatography with mass-spectrometric detection.
Erin R Lepper, J Kevin Hicks, Jaap Verweij, Suoping Zhai, William D Figg

J Chromatogr B Analyt Technol Biomed Life Sci· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma.
Susan E Bates, Susan Bakke, Min Kang, Robert W Robey, Suoping Zhai

Clin Cancer Res· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of MS-275, a novel histone deacetylase inhibitor, in human plasma by liquid chromatography-electrospray mass spectrometry.
Kyunghwa Hwang, Milin R Acharya, Edward A Sausville, Suoping Zhai, Eunhee W Woo

J Chromatogr B Analyt Technol Biomed Life Sci· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer.
Mahrukh M Hussain, Herbert Kotz, Lori Minasian, Ahalya Premkumar, Gisele Sarosy, Suoping Zhai

J Clin Oncol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women.
Maureen D Passaro, Johann Piquion, Nancy Mullen, Dorette Sutherland, Suoping Zhai

Hum Reprod· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacology and pharmacogenetics of flavopiridol 1-h i.v. infusion in patients with refractory neoplasms.
Suoping Zhai, Edward A Sausville, Adrian M Senderowicz, Yuichi Ando, Donna Headlee

Anticancer Drugs· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical and pharmacokinetic study of flavopiridol administered as a daily 1-hour infusion in patients with advanced neoplasms.
Antoinette R Tan, Donna Headlee, Richard Messmann, Edward A Sausville, Susan G Arbuck, Suoping Zhai

J Clin Oncol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high-performance liquid chromatography method using ultraviolet detection for the quantitation of flavopiridol from human plasma.
Suoping Zhai, Edward Sausville, William D Figg

Biomed Chromatogr· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development.
Suoping Zhai, Adrian M Senderowicz, Edward A Sausville, William D Figg

Ann Pharmacother· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of prolonged infusions of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia.
Steven D Gore, Li-Jun Weng, William D Figg, Suoping Zhai, Ross C Donehower

Clin Cancer Res· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of paclitaxel administered by hyperthermic retrograde isolated lung perfusion techniques.
David S Schrump, Suoping Zhai, Dao M Nguyen, Todd S Weiser, Bradley A Fisher

J Thorac Cardiovasc Surg· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis